{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:06:03Z","timestamp":1779782763006,"version":"3.53.1"},"reference-count":50,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000991","name":"Faculty of Medicine, Nursing and Health Sciences, Monash University","doi-asserted-by":"publisher","award":["Monash Graduate Scholarship"],"award-info":[{"award-number":["Monash Graduate Scholarship"]}],"id":[{"id":"10.13039\/501100000991","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT190100218"],"award-info":[{"award-number":["FT190100218"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DE220100456"],"award-info":[{"award-number":["DE220100456"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2025894"],"award-info":[{"award-number":["2025894"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To characterize psychotropic medicine utilization and identify its correlates in injured Australian workers with back and neck\u2010related conditions following a workers' compensation claim.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Psychotropic medicine utilization (antidepressants, gabapentinoids, anxiolytics, hypnotics\/sedatives and antipsychotics) was examined among 22\u2009595 injured workers with accepted claims (2010\u20132016) in Victoria, Australia, over three years post\u2010claim. The defined daily dose (DDD) per 1000 workers per day was used to describe utilization and temporal trends. Zero\u2010inflated negative binomial regression was employed to identify its determinants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall utilization (DDD\/1000\/day) of psychotropics for all\u2010injured workers was 135.4 (CI: 128.8\u2013142.1), highest for antidepressants (74.2, CI: 70\u201378.5), followed by gabapentinoids (31.6, CI: 29.7\u201333.5), anxiolytics (16.1, CI: 14.7\u201317.6), hypnotics\/sedatives (10.6, CI: 9.4\u201311.8) and antipsychotics (2.9, CI: 2.3\u20133.4). Workers with longer periods of disability showed increasing utilization across each medicine group and for psychotropic medications overall. Middle age was associated with higher utilization while higher socioeconomic status and living regionally were associated with lower psychotropic utilization. Gabapentinoid utilization (more than doubled (109.2%) from 20.7 in 2010 to 43.3 in 2016. Conversely, anxiolytics and hypnotics\/sedatives utilization showed a relative decrease over the study period. The utilization of psychotropics increased among injured workers across the course of their claim.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Psychotropic medicine utilization in compensated Australian workers with back or neck conditions was high, particularly in those with longer disability duration. Psychotropic prescribing has changed over time, with a notable increase in gabapentinoid utilization. Furthermore, a trend indicating long\u2010term or higher\u2010dose use of psychotropics was observed, raising concerns of potential overuse.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/bcp.70426","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T03:03:47Z","timestamp":1766372627000},"page":"1625-1640","source":"Crossref","is-referenced-by-count":1,"title":["Psychotropic medicine utilization in Australian workers with workers' compensation claims for back and neck musculoskeletal disorders or injuries"],"prefix":"10.1002","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9205-9442","authenticated-orcid":false,"given":"Yonas Getaye","family":"Tefera","sequence":"first","affiliation":[{"name":"Healthy Working Lives Research Group, School of Public Health and Preventive Medicine Monash University  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-1055","authenticated-orcid":false,"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Monash Addiction Research Centre, Eastern Health Clinical School Monash University  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Gray","sequence":"additional","affiliation":[{"name":"Healthy Working Lives Research Group, School of Public Health and Preventive Medicine Monash University  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Di Donato","sequence":"additional","affiliation":[{"name":"Healthy Working Lives Research Group, School of Public Health and Preventive Medicine Monash University  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke R.","family":"Sheehan","sequence":"additional","affiliation":[{"name":"Healthy Working Lives Research Group, School of Public Health and Preventive Medicine Monash University  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Collie","sequence":"additional","affiliation":[{"name":"Healthy Working Lives Research Group, School of Public Health and Preventive Medicine Monash University  Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"Australian Government Quality Aged Care Safety Commission.Psychotropic medications used in Australia: information for aged care.2020. Available at:https:\/\/www.agedcarequality.gov.au\/resource-library\/psychotropic-medications-used-australia-information-aged-care"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(17)32802\u20107"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20204"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6470"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.1.19"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa0906126"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215\u20100366(21)00292\u20103"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.07.001"},{"key":"e_1_2_11_10_1","unstructured":"OECD.2017.Health at a Glance 2017: OECD Indicators OECD Publishing 2017. Paris France. (Accessed September 15 2023) Available from: doi:10.1787\/health_glance\u20102017\u2010en."},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326\u20105377.2009.tb02522.x"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5158"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10926\u2010018\u20109816\u20104"},{"key":"e_1_2_11_14_1","volume-title":"Comparison of workers' compensation arrangements in Australia and New Zealand 2021","author":"Safe Work Australia"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10926\u2010019\u201009862\u20101"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/oemed\u20102019\u2010105995"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10926\u2010023\u201010098\u20103"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj\u20102022\u2010072415"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4825"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1315"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1704633"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0000000000000557"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0000000000000333"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0000000000001585"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263\u2010016\u20100359\u2010y"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000506868"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000507897"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3532"},{"key":"e_1_2_11_29_1","volume-title":"Statistics, labour force, Australia august 2023","author":"Australian Bureau of Statistics (ABS)","year":"2023"},{"key":"e_1_2_11_30_1","unstructured":"World Health Organization.WHO Collaborating Centre for Drug Statistics Methodology Guidelines for ATC classification and DDD assignment 2023. 26th edition; Oslo Norway: Norwegian Institute of Public Health2022: 252."},{"key":"e_1_2_11_31_1","unstructured":"Australian Safety and Compensation Council.Type Of Occurrence Classification System (TOOCS); Third edition Revision 1. Canberra:Australian Government: Australian Safety and Compensation Council;May 2008. 292 p."},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102012\u2010002396"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy9010060"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4168"},{"key":"e_1_2_11_35_1","volume-title":"Australian standard classification of occupations","author":"Australian Bureau of Statistics","year":"1997"},{"key":"e_1_2_11_36_1","volume-title":"2006 RA from 2006 POA correspondence. Australian standard geographical classification (ASGC) remoteness area correspondences","author":"Australian Bureau of Statistics (ABS)","year":"2011"},{"key":"e_1_2_11_37_1","volume-title":"Postal area, indexes, SEIFA 2016. Census of population and housing: socio\u2010economic indexes for areas (SEIFA), Australia","author":"Australian Bureau of Statistics (ABS)","year":"2016"},{"key":"e_1_2_11_38_1","volume-title":"Stata statistical software: release 17","author":"StataCorp","year":"2021"},{"key":"e_1_2_11_39_1","unstructured":"BrodyDJGuQ2020Antidepressant use among adults: United States 2015\u20132018"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674221079740"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.01.039"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889\u2010022\u201014677\u20106"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468\u20102667(19)30248\u20108"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867412466595"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.4773"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867420979353"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0000000000002344"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/oemed\u20102023\u2010109369"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674211067720"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.4023"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13369"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70426","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bcp.70426","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:45:58Z","timestamp":1779781558000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/bcp.70426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1002\/bcp.70426"],"URL":"https:\/\/doi.org\/10.1002\/bcp.70426","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]}}}